Analyst Group write about our new indication on migraine

Read their analysis in Swedish. Chordate Medical – Resultatet från migränstudien kan bli stor värdedrivare

Chordate CEO Anders Weilandt explains the company offering

Kista, May 29 2019. Chordate CEO Anders Weilandt participated in the live event “Småbolagsjakten Live” yesterday at GT30 in Stockholm. Our CEO Anders Weilandt presented our offering including the new indication on migrane. Watch the video and learn about both our offering in rinithis and in migrane. The presentation is made in Swedish. For more information, please contact: Anders Weilandt, CEO Telefon: +46 (0) […]